Exhibit 10.19
THIRD AMENDMENT TO
REVOLVING CREDIT AGREEMENT
--------------------------
THIS THIRD AMENDMENT TO REVOLVING CREDIT AGREEMENT (this "Third Amendment")
is made and entered into as of August 1, 2001, by and among (a) MILLIPORE
CORPORATION, a Massachusetts corporation having its principal place of business
at ▇▇ ▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ (the "Borrower"), (b) FLEET NATIONAL BANK
(f/k/a BANKBOSTON N.A.), with an office at ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇,
▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ("Fleet"), ABN AMRO BANK N.V., with its Boston branch at ▇▇▇
▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ("ABN"), and the other lending
institutions party hereto (collectively with Fleet and ABN, the "Banks") and (c)
FLEET, as administrative agent for the Banks (the "Administrative Agent"), and
ABN, as documentation agent for the Banks (the "Documentation Agent," and
collectively with the Administrative Agent, the "Agents").
WHEREAS, the Borrower, the Agents and the Banks are party to that Revolving
Credit Agreement dated as of January 22, 1997, which was amended pursuant to
that certain First Amendment, dated as of February 11, 1997, and by the Second
Amendment, dated as of September 30, 1998 (as amended the "Credit Agreement");
WHEREAS, the Borrower has announced its intention to spin-off its wholly-
owned Subsidiary Mykrolis Corporation, a Delaware corporation ("Mykrolis"), in
two phases: (1) an initial public offering of less than 20% of the outstanding
shares of Mykrolis common stock and (2) a subsequent distribution of the
remaining shares of Mykrolis to the Borrower's shareholders;
WHEREAS, the Borrower has requested that the Banks make certain revisions
to the Credit Agreement as hereinafter set forth, and the Banks have agreed to
such revisions;
NOW, THEREFORE, for good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereto agree as
follows:
1. DEFINITIONS. Capitalized terms used herein without definition shall
have the meanings assigned to such terms in the Credit Agreement.
2. AMENDMENTS TO (S)1.1.
--------------------
1
(a) The definition of "Consolidated Earnings Before Interest, Taxes,
Depreciation and Amortization or EBITDA" in (S)1.1 of the Credit Agreement is
deleted in its entirety and the following new definition is inserted in its
place:
"Consolidated Earnings Before Interest, Taxes, Depreciation and
Amortization or EBITDA. For any period, without duplication, Consolidated
Net Income (or Deficit) plus in each case to the extent deducted from
Consolidated Net Income (or Deficit) (a) Consolidated Total Interest
Expense, (b) income taxes, (c) depreciation expense, (d) amortization
expense, (e) restructuring charges and other one time expense items in
connection with Mykrolis, not to exceed $12,600,000 in the aggregate,
deducted as a special charge in the quarter ending ▇▇▇▇▇ ▇▇, ▇▇▇▇, (▇) loss
attributed to the discontinued operations of Mykrolis, not to exceed
$6,000,000, taken in the fiscal quarter ending June 30, 2001, and (g) net
loss with respect to the disposal of discontinued operations of Mykrolis,
not to exceed $30,000,000, taken in the fiscal quarter ending June 30,
2001; provided that, for purposes of calculating the financial covenants
pursuant to (S)9, the portion of EBITDA derived from Subsidiaries acquired
since the date of the most recent financial statements delivered to the
Banks pursuant to (S)7.4 hereof shall be included in the calculation of
EBITDA if (i) the financial statements of such acquired Subsidiaries have
been audited for the period sought to be included by an independent
accounting firm satisfactory to the Administrative Agent or (ii) the
Administrative Agent consents to such inclusion, such consent not to be
unreasonably withheld."
(b) The following new definitions are added to (S)1.1 in the proper
alphabetical order therein:
"Third Amendment Effective Date. The date on which conditions in (S)11
of the Third Amendment to the Credit Agreement dated August 1, 2001 are
satisfied."
"Mykrolis. Mykrolis Corporation, a Delaware corporation, and a wholly-
owned Subsidiary of the Borrower prior to the Mykrolis IPO."
2
"Mykrolis IPO. The initial public offering of shares of Mykrolis
(which shall constitute less than 20% of the Mykrolis Stock)."
"Mykrolis Shareholder Distribution. Subsequent to the Mykrolis IPO,
the Distribution of the remaining shares of Mykrolis Stock by the Borrower
to the Borrower's shareholders."
"Mykrolis Stock. All outstanding shares of common stock of Mykrolis."
3. AMENDMENT TO (S)2.1. Section 2.1 is hereby amended by deleting
clause (i) appearing therein and replacing it with a new clause (i) as follows:
"(i) $175,000,000, as such amount may be reduced after the Third Amendment
Effective Date pursuant to (S)2.3 hereof (the "Total Commitment") minus".
4. AMENDMENT TO (S)8.1. Section 8.1 is hereby amended by deleting the
"and" appearing at the end of subsection (j), changing the current subsection
(k) to subsection (l), and inserting a new subsection (k) as follows:
"(k) Liens to secure Indebtedness of Mykrolis and Mykrolis' Subsidiaries
not to exceed $35,000,000; provided that such Liens are only on the assets
of Mykrolis and Mykrolis' Subsidiaries and/or the stock of Mykrolis'
Subsidiaries and that such Indebtedness is non-recourse to the Borrower and
its other Subsidiaries (other than with respect to the stock of Mykrolis'
Subsidiaries); and"
5. AGREEMENTS CONCERNING MYKROLIS.
(a) The Borrower acknowledges and agrees that nothing herein shall be
construed as a consent of the Administrative Agent or the Banks to the Mykrolis
Shareholder Distribution, and that prior to the Mykrolis Shareholder
Distribution, the Borrower shall obtain the consent of the Majority Banks.
(b) The Borrower agrees that any loans to, investment in, Distribution to
or any non-arms length arrangement or other support arrangement for the benefit
of Mykrolis and Mykrolis' Subsidiaries made
3
following the Mykrolis IPO shall be deducted from the Investment basket under
(S)8.2(g) of the Credit Agreement.
6. AGREEMENT CONCERNING (S)7.18. The receipt by the Borrower of the Met
Life Waiver, as defined in (S)7(e) of this Third Amendment, shall constitute
compliance with (S)7.18 of the Credit Agreement in relation to this Third
Amendment.
7. REPRESENTATIONS AND WARRANTIES. The Borrower represents and warrants
as follows:
(a) The execution and delivery of this Third Amendment (i) is within the
corporate authority of the Borrower, (ii) has been duly authorized by all
necessary corporate proceedings on the part of the Borrower, (iii) does not
conflict with or result in any material breach or contravention of any provision
of law, statute, rule or regulation to which the Borrower is subject or any
judgment, order, writ, injunction, license or permit applicable to the Borrower
so as to materially adversely affect the assets, business or any activity of the
Borrower, and (iv) does not conflict with any provision of the corporate charter
or bylaws of the Borrower or any agreement or other instrument binding upon the
Borrower.
(b) The Mykrolis IPO does not conflict with any provision of the corporate
charter or bylaws of the Borrower or any material agreement binding upon the
Borrower and its Subsidiaries.
(c) The execution and delivery of this Third Amendment and the performance
of the transactions contemplated hereby will result in valid and legally binding
obligations of the Borrower party thereto enforceable against the Borrower in
accordance with the respective terms and provisions hereof and thereof, except
as enforceability is limited by bankruptcy, insolvency, reorganization,
moratorium or other laws relating to or affecting generally the enforcement of
creditors rights and except to the extent that availability of the remedy of
specific performance or injunctive relief is subject to the discretion of the
court before which any proceeding therefor may be brought.
(d) As of the Third Amendment Effective Date, no Default or Event of
Default or condition which would result in a Default or Event of Default has
occurred and is continuing (except that which would have occurred but for the
modifications contained in this Third Amendment).
4
(e) The Borrower has obtained a ninety day waiver from Metropolitan Life
Insurance Company ("Met Life") with respect to the Note Purchase Agreement for
any financial covenant defaults thereunder that arise out of the matters
described in clauses (e), (f) and (g) of the definition of EBITDA in (S)1.1 of
the Credit Agreement as amended by this Third Amendment (the "Met Life Waiver").
(f) The Borrower will use its reasonable best efforts to obtain either a
permanent amendment to the Note Purchase Agreement with Met Life on terms which
mirror or are no more restrictive than the Credit Agreement or to obtain an
extension of the waiver until the Maturity Date.
(g) Taking into account the Met Life Waiver, as of the Third Amendment
Effective Date, no default or event of default exists under any other
Indebtedness of the Borrower or its Subsidiaries.
(h) The Mykrolis IPO will not create a Default or Event of Default.
8. RATIFICATION, ETC. Except as expressly amended hereby, the Credit
Agreement, the other Loan Documents and all documents, instruments and
agreements related thereto are hereby ratified and confirmed in all respects and
shall continue in full force and effect. This Third Amendment and the Credit
Agreement shall hereafter be read and construed together as a single document,
and all references in the Credit Agreement, any other Loan Document or any
agreement or instrument related to the Credit Agreement shall hereafter refer to
the Credit Agreement as amended by this Third Amendment.
9. GOVERNING LAW. THIS THIRD AMENDMENT SHALL BE GOVERNED BY AND
CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE COMMONWEALTH OF MASSACHUSETTS
(WITHOUT REFERENCE TO CONFLICT OF LAWS) AND SHALL TAKE EFFECT AS A SEALED
INSTRUMENT IN ACCORDANCE WITH SUCH LAWS.
10. COUNTERPARTS. This Third Amendment may be executed in any number of
counterparts and by different parties hereto on separate counterparts, each of
which when so executed and delivered shall be an original, but all of which
counterparts taken together shall be deemed to constitute one and the same
instrument.
11. EFFECTIVENESS.
5
(a) This Third Amendment (other than (S)4) shall become effective upon the
satisfaction of the following conditions (the "Third Amendment Effective Date"):
(i) This Third Amendment shall have been executed and delivered by the
respective parties hereto, including the Majority Banks;
(ii) All corporate action necessary for the valid execution and
delivery by the Borrower of this Third Amendment and the performance of the
transactions contemplated hereby and thereby shall have been taken, and
satisfactory evidence thereof shall have been provided to the
Administrative Agent;
(iii) The Borrower shall have paid to each Bank that has executed and
delivered this Third Amendment prior to the close of business on July 30,
2001, an amendment fee, which shall be in an amount equal to 0.125% of each
such Bank's Commitment as in effect immediately prior to the Third
Amendment Effective Date; and
(iv) The Borrower shall have reimbursed the Administrative Agent for
all costs and expenses (including legal fees) incurred by the
Administrative Agent in connection with the closing of this Third
Amendment, to the extent such costs and expenses have been invoiced to the
Borrower on or before the latest to occur of the conditions in clauses (i),
(ii) and (iii) of this (S)10(a); and
(v) The Administrative Agent shall have received a copy of the Met
Life Waiver.
(b) Following the Third Amendment Effective Date, (S)4 of this Third
Amendment shall become effective upon the occurrence of the Mykrolis IPO,
provided that the Borrower shall own at least 80% of the Mykrolis Stock and
evidence thereof shall have been provided to the Administrative Agent.
[Remainder of Page Intentionally Left Blank]
6
IN WITNESS WHEREOF, each of the undersigned has duly executed this Third
Amendment under seal as of the date first set forth above.
THE BORROWER:
------------
MILLIPORE CORPORATION
By: /s/ ▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇
-----------------------------
Name: ▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇
Title: Vice President and CFO
THE BANKS AND AGENTS:
--------------------
FLEET NATIONAL BANK
(f/k/a/ BANKBOSTON, N.A.), individually and as
Agent
By: /s/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇
-----------------------------
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇
Director
ABN AMRO BANK N.V.
By: /s/ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇
-----------------------------
Name: ▇▇▇▇▇▇▇ ▇▇▇▇▇▇
Title: Group Vice President
By: /s/ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇
-----------------------------
Name: ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇
Title: Vice President
7
BANK OF TOKYO-MITSUBISHI TRUST COMPANY
By: /s/ ▇. ▇▇▇▇▇▇▇▇▇
-----------------------------
Name: ▇. ▇▇▇▇▇▇▇▇▇
Title: Vice President
By:
-----------------------------
Name:
Title:
THE CHASE MANHATTAN BANK
By: /s/ A. ▇▇▇▇ ▇▇▇▇▇▇
-----------------------------
Name: A. ▇▇▇▇ ▇▇▇▇▇▇
Title: Vice President
THE BANK OF NOVA SCOTIA
By: /s/ Unreadable
-----------------------------
Name:
Title: Authorized Signatory
By:
-----------------------------
Name:
Title:
8
THE SANWA BANK, LIMITED
By: /s/ ▇▇▇▇▇▇ ▇. ▇▇▇
-----------------------------
Name: ▇▇▇▇▇▇ ▇. ▇▇▇
Title: Vice President and
Area Manager
By:
-----------------------------
Name:
Title:
CITIZENS BANK OF MASSACHUSETTS
By: /s/ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇
-----------------------------
Name: ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇
Title: Vice President
By:
-----------------------------
Name:
Title:
THE DAI-ICHI KANGYO
BANK, LTD.
By: /s/ J. ▇▇▇▇▇▇▇ ▇▇▇▇▇▇
-----------------------------
Name: J. ▇▇▇▇▇▇▇ ▇▇▇▇▇▇
Title: Senior Vice President
By:
-----------------------------
Name:
Title:
9
▇▇▇▇▇▇ GUARANTY TRUST COMPANY OF NEW YORK
By: /s/ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇
-----------------------------
Name: ▇▇▇▇▇ ▇▇▇▇▇▇▇▇
Title: Vice President
MELLON BANK, N.A.
By: /s/ ▇▇▇▇▇ ▇▇▇▇▇▇
-----------------------------
Name: ▇▇▇▇▇ ▇▇▇▇▇▇
Title: Vice President
By:
-----------------------------
Name:
Title:
SUMITOMO MITSUI BANKING COPORATION
(F/K/A THE SUMITOMO BANK LIMITED, AND AS SUCCESSOR
BY MERGER TO THE SAKURA BANK, LIMITED)
By: /s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇
------------------------------
Name: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇
Title: Senior Vice President
10
BANKERS TRUST COMPANY
By:
-----------------------------
Name:
Title:
By:
-----------------------------
Name:
Title:
CREDIT LYONNAIS NEW YORK BRANCH
By: /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇
-----------------------------
Name: ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇
Title: Vice President
By:
-----------------------------
Name:
Title:
▇▇
▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇-▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇, ▇▇▇ ▇▇▇▇
BRANCH
By: /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
-----------------------------
Name: ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
Title: Director
By: /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇
-----------------------------
Name: ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇
Title: Associate Director
UNICREDITO ITALIANO SPA
By: /s/ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇
-----------------------------
Name: ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇
Title: First Vice President
By: /s/ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇
-----------------------------
Name: ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇
Title: Vice President
12
